📊 SNWV Key Takeaways
Is SANUWAVE Health, Inc. (SNWV) a Good Investment?
SANUWAVE demonstrates impressive revenue growth (+35% YoY) and exceptional gross margins (77.3%), indicating strong market demand and operational efficiency. However, these strengths are severely undermined by persistent unprofitability (-$1.4M net loss), unsustainable leverage (11.16x debt-to-equity), and inability to service debt from operations (negative 2.1x interest coverage), creating material default risk despite positive free cash flow.
SANUWAVE Health, Inc. Key Strengths (SNWV)
- Strong revenue growth of 35% YoY demonstrating significant market traction
- Exceptional gross margin of 77.3% indicating strong pricing power and efficient production
- Positive free cash flow of $374K despite operating losses shows disciplined working capital management
- Cash position of $10.8M provides near-term operational runway
SNWV Stock Risks: SANUWAVE Health, Inc. Investment Risks
- Dangerously high leverage with debt-to-equity of 11.16x and long-term debt of $20.5M versus only $1.8M stockholders' equity creates insolvency risk
- Cannot cover interest payments from operations (negative 2.1x interest coverage) indicating potential covenant violations or refinancing pressure
- Operating margin deeply negative at -11.7% shows SG&A and R&D expenses are not controlled relative to revenue scale
- Tight liquidity with quick ratio of 0.99x leaves minimal margin for error
- Company remains unprofitable with net loss of $1.4M despite strong revenue, suggesting path to profitability unclear
Key Metrics to Watch
- Operating margin trajectory - must improve significantly to justify debt load; target positive operating income within 2-3 quarters
- Debt reduction progress - monitor long-term debt levels and refinancing activity; watch for debt covenant compliance disclosures
- Operating cash flow sustainability - verify if positive OCF of $397K can be maintained and expanded as revenue scales
SANUWAVE Health, Inc. (SNWV) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The relatively thin 3.9% FCF margin may limit capital allocation flexibility.
SNWV Profit Margin, ROE & Profitability Analysis
SNWV vs Healthcare Sector: How SANUWAVE Health, Inc. Compares
How SANUWAVE Health, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is SANUWAVE Health, Inc. Stock Overvalued? SNWV Valuation Analysis 2026
Based on fundamental analysis, SANUWAVE Health, Inc. shows some fundamental concerns relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
SANUWAVE Health, Inc. Balance Sheet: SNWV Debt, Cash & Liquidity
SNWV Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: SANUWAVE Health, Inc.'s revenue has grown significantly by 697% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.00 indicates the company is currently unprofitable.
SNWV Revenue Growth, EPS Growth & YoY Performance
SNWV Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $9.3M | $5.7M | $0.38 |
| Q2 2025 | $7.1M | $1.1M | $0.01 |
| Q1 2025 | $5.7M | -$4.5M | $-0.66 |
| Q3 2024 | $4.8M | -$18.6M | $-5.92 |
| Q2 2024 | $4.4M | $2.0M | $0.00 |
| Q1 2024 | $3.5M | -$4.5M | $0.00 |
| Q3 2023 | $3.9M | -$1.1M | $0.00 |
| Q2 2023 | $3.5M | $1.6M | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
SANUWAVE Health, Inc. Dividends, Buybacks & Capital Allocation
SNWV SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for SANUWAVE Health, Inc. (CIK: 0001417663)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SNWV
What is the AI rating for SNWV?
SANUWAVE Health, Inc. (SNWV) has an AI grade of C with 72% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SNWV's key strengths?
Claude: Strong revenue growth of 35% YoY demonstrating significant market traction. Exceptional gross margin of 77.3% indicating strong pricing power and efficient production.
What are the risks of investing in SNWV?
Claude: Dangerously high leverage with debt-to-equity of 11.16x and long-term debt of $20.5M versus only $1.8M stockholders' equity creates insolvency risk. Cannot cover interest payments from operations (negative 2.1x interest coverage) indicating potential covenant violations or refinancing pressure.
What is SNWV's revenue and growth?
SANUWAVE Health, Inc. reported revenue of $9.6M.
Does SNWV pay dividends?
SANUWAVE Health, Inc. does not currently pay dividends.
Where can I find SNWV SEC filings?
Official SEC filings for SANUWAVE Health, Inc. (CIK: 0001417663) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SNWV's EPS?
SANUWAVE Health, Inc. has a diluted EPS of $-0.17.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is SNWV's fundamental grade?
Based on our AI fundamental analysis in June 2026, SANUWAVE Health, Inc. has a C grade with 72% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is SNWV stock overvalued or undervalued?
Valuation metrics for SNWV: ROE of -78.3% (sector avg: 15%), net margin of -15.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is SNWV's AI grade for 2026?
Our dual AI analysis gives SANUWAVE Health, Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SNWV's free cash flow?
SANUWAVE Health, Inc.'s operating cash flow is $397.0K, with capital expenditures of $23.0K. FCF margin is 3.9%.
How does SNWV compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -15.0% (avg: 12%), ROE -78.3% (avg: 15%), current ratio 1.31 (avg: 2).
Is SANUWAVE Health, Inc. carrying too much debt?
SNWV has a debt-to-equity ratio of 11.16x, which is above the Healthcare sector average of 0.6x. However, the current ratio of 1.31 suggests adequate short-term liquidity.